Tuberous Sclerosis Complex: A Review.
Randle SC.
Pediatr Ann. 2017 Apr 1;46(4):e166-e171. doi: 10.3928/19382359-20170320-01.
Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
Klonowska K, Thiele EA, Grevelink JM, Thorner AR, Kwiatkowski DJ.
J Med Genet. 2022 Sep;59(9):920-923. doi: 10.1136/jmedgenet-2021-108160. Epub 2021 Oct 11.
Phakomatoses.
Becker B, Strowd RE 3rd.
Dermatol Clin. 2019 Oct;37(4):583-606. doi: 10.1016/j.det.2019.05.015.
Facial Angiofibroma Severity Index: A beneficial tool to evaluate the treatment response in the skin of colour.
Hongal AA, Aithal SS, Revathi TN.
Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):130-132. doi: 10.25259/IJDVL_1161_2021.
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Boggarapu S, Roberds SL, Nakagawa J, Beresford E.
Orphanet J Rare Dis. 2022 Sep 14;17(1):355. doi: 10.1186/s13023-022-02496-2.
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ.
Am J Hum Genet. 2001 Jan;68(1):64-80. doi: 10.1086/316951. Epub 2000 Dec 8.
Tuberous sclerosis.
Fryer AE.
J R Soc Med. 1991 Dec;84(12):699-701. doi: 10.1177/014107689108401202.
Tuberous sclerosis.
Curatolo P, Bombardieri R, Jozwiak S.
Lancet. 2008 Aug 23;372(9639):657-68. doi: 10.1016/S0140-6736(08)61279-9.
Tuberous Sclerosis.
Diaconita V, Shteyman A, Jolia A, Tsang SH, Sharma T, Marr B.
Adv Exp Med Biol. 2025;1467:229-233. doi: 10.1007/978-3-031-72230-1_45.
Tuberous sclerosis.
Almutairi A, Hundallah K.
Neurosciences (Riyadh). 2019 Oct;24(4):335-337. doi: 10.17712/nsj.2019.4.20190107.
